Evidence map›Paper›PMID 34206348›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Antimicrobial Resistance Determinants in Genomes and Plasmids from

Itziar Chapartegui-González, María Lázaro-Díez, Santiago Redondo-Salvo, Jesús Navas, José Ramos-Vivas

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Microbiology spectrum · 2022
    Article
  5. Biological Control ofMicroorganisms · 2022
    Review
  6. Genetic Resistance Determinants in ClinicalAntibiotics (Basel, Switzerland) · 2022
    Article
  7. Genetic Diversity of Antimicrobial Resistance and Key Virulence Features in Two Extensively Drug-ResistantInternational journal of environmental research and public health · 2022
    Article
  8. Emergence of uncommon KL38-OCL6-ST220 carbapenem-resistantFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Itziar Chapartegui-GonzálezDepartment of Microbiology and Immunology, UTMB, Galveston, TX 77550, USA.ORCID 0000-0001-7878-4499
María Lázaro-DíezInstituto de Agrobiotecnología, CSIC-Gobierno de Navarra, 31192 Mutilva, Spain.ORCID 0000-0002-6098-8052
Santiago Redondo-SalvoInstituto de Biomedicina y Biotecnología de Cantabria (IBBTEC), Universidad de Cantabria-CSIC, 39011 Santander, Spain.ORCID 0000-0003-0089-6030
Jesús NavasGrupo BIOMEDAGE, Facultad de Medicina, Universidad de Cantabria, 39011 Santander, Spain.ORCID 0000-0001-5735-4668
José Ramos-VivasResearch Group on Foods, Nutritional Biochemistry and Health, Universidad Europea del Atlántico, 39011 Santander, Spain.ORCID 0000-0001-8795-519X

Funding

European Regional Development Fund RED2018-102469-TInstituto de Salud Carlos III PI16/01103Spanish Network for Research in Infectious Diseases REIPI RD12/0015Spanish Network for Research in Infectious Diseases REIPI RD16/0016
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacter baumanniiantimicrobial determinantsbioinformaticsESKAPE pathogensIlluminaplasmidsWGS

Identifiers

PMID34206348
PMCPMC8300758

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.